Repair defect in P21WAF1/CIP1 -/- human cancer cells

Cancer Research

Volumn 56, Issue 10, 1996, Pages 2250-2255

  McDonald III, E Robert ^a   Wu, Gen Sheng ^a   Waldman, Todd ^b   El Deiry, Wafik S ^a,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; CYCLIN DEPENDENT KINASE; PROTEIN P21;

ARTICLE; CANCER INHIBITION; CARBOXY TERMINAL SEQUENCE; COLON CARCINOGENESIS; COLON CARCINOMA; DNA CLEAVAGE; GENE EXPRESSION REGULATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REPORTER GENE; TUMOR SUPPRESSOR GENE;

CELL CYCLE; CELL DIVISION; CISPLATIN; COLONIC NEOPLASMS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DNA DAMAGE; DNA REPAIR; DNA REPLICATION; DNA, NEOPLASM; GENES, REPORTER; HUMANS; NEOPLASM PROTEINS; PROLIFERATING CELL NUCLEAR ANTIGEN; THIOGUANINE; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY; TUMOR SUPPRESSOR PROTEIN P53; ULTRAVIOLET RAYS;

EID: 0030002545     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. El-Deiry, W. S., Tokino, T , Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinder, K. W., and Vogelstein, B WAF1, a potential mediator of p53 tumor suppression. Cell, 75: 817-825, 1993.
2. Harper, J. W., Adami, G R., Wei, N., Keyomarsi, K., and Elledge, S. J. The p21 cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell, 75: 805-816, 1993.
3. Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R., and Beach, D. p21 is a universal inhibitor of cyclin kinases. Nature (Lond.), 366: 701-704, 1993.
4. Waga, S., Hannon, G. J , Beach, D., and Stillman, B The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature (Lond.), 369: 574-578, 1994.
5. Symonds, H., Krall, L., Remington, L., Saenz-Robles, M., Lowe, S., Jacks, T., and Van Dyke, T. p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell, 78: 703-711, 1994.
6. Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M J., Montgomery, C. A., Jr., Butel, J. S., and Bradley, A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature (Lond.), 356: 215-221, 1992
7. Lowe, S. W , Ruley, H. E., Jacks, T., and Housman, D. E. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell, 74: 957-967, 1993
8. Hartwell, L. H., and Kastan, M. B. Cell cycle control and cancer Science (Washington DC), 266: 1821-1828, 1994.
9. 1 checkpoint-competent cells. Cancer Res., 55: 1639-1642, 1995.
10. 2 delay. Cancer Res., 55: 1643-1648, 1995
11. Fan, S., Smith, M. L., Rivet, II, D. J., Duba, D., Zhan, Q., Kohn, K W., Fornace, Jr., A. J., and O'Connor, P. M Disruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxifyline Cancer Res., 55: 1649-1654, 1995.
12. 1 arrest. Cell, 76: 1013-1024, 1994.
13. 1 arrest and apoptosis. Cancer Res., 54: 1169-1174, 1994.
14. 1 checkpoint control. Cell, 82: 675-684, 1995
15. Brugarolas, J., Chandrasekaran, C , Gordon, J. I., Beach, D., Jacks, T , and Hannon, G. J. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature (Lond.), 377: 552-557, 1995.
16. 1 arrest in human cancer cells. Cancer Res., 55: 5187-5190, 1995.
17. Sands, A. T., Suraokar, M. B., Sanchez, A., Marth, J E., Donehower, L. A., and Bradley, A. p53 deficiency does not affect the accumulation of point mutations in a transgene target. Proc. Natl. Acad. Sci. USA, 92: 8517-8521, 1995.
18. Nishino, H., Knoll, A., Buettner, V. L., Frisk, C. S., Maruta, Y., Haavik, J , and Sommer, S. S. p53 wild-type and p53 nullizygous Big Blue transgenic mice have similar frequencies and patterns of observed mutation in liver, spleen and brain. Oncogene, 11 263-270, 1995.
19. Havre, P. A., Yuan, J., Hedrick, L., Cho, K. R., and Glazer, P. M. p53 inactivation by HPV16 E6 results in increased mutagenesis in human cells. Cancer Res., 55: 4420-4424, 1995.
20. Zeng-Rong, N., Paterson, J , Alpert, L , Tsao, M-S , Viallet, J., and Alaoui-Jamali, M. A. Elevated DNA repair capacity is associated with intrinsic resistance of lung cancer to chemotherapy. Cancer Res., 55: 4760-4764, 1995.
21. Eshleman, J R., Lang, E. Z., Bowerfind, G. K., Parsons, R., Vogelstein, B., Willson, I. K. V., Veigl, M. L , Sedwick, W. D , and Markowitz, S. D. Increased mutation rate at the hprt locus accompanies microsatellite instability in colon cancer. Oncogene, 10: 33-37, 1995.
22. Li, R., Waga, S., Hannon, G J., Beach, D., and Stillman, B. Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair. Nature (Lond.), 371: 534-537, 1994.
23. Shivji, M. K. K., Grey, S. J., Strausfeld, U. P., Wood, R. D. and Blow, J. J Cip1 inhibits DNA replication but not PCNA-dependent nucleotide excision-repair. Curr. Biol., 4: 1062-1068, 1994.
24. Pan, Z-Q., Reardon, J. T., Li, L., Flores-Rozas, H., Legerski, R , Sancar, A., and Hurwitz, J. Inhibition of nucleotide excision repair by the cyclin-dependent kinase inhibitor p21. J. Biol Chem., 270: 22008-22016, 1995.
25. CIP1-related domain to bind cyclin/cdk2 and regulate interactions with E2F. Genes & Dev., 9: 1740-1752, 1995.
26. Smith, M. L , Chen, I-T., Zhan, Q., Bae, I., Chen, C-Y., Gilmer, T M., Kastan, M. B., O'Connor, P. M., and Fornace, A. J., Jr. Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen. Science (Washington DC), 266: 1376-1380, 1994.
27. Cip1. Oncogene, 11: 1675-1683, 1995.
28. WafI/Cip1 with PCNA. Oncogene, 11: 1931-1937, 1995.
29. Cip1. Nature (Lond.), 375: 159-161, 1995.
30. Athas, W. F , Hedayati, M. A., Matanoski, G. M., Farmer, E. R., and Grossman, L. Development and field-test validation of an assay for DNA repair in circulating human lymphocytes. Cancer Res., 51: 5786-5793, 1991.
31. Sheibani, N., Jennerwein, M. M., and Eastman, A. DNA repair in cells sensitive and resistant to cis-diamminedichloro-platinum(II): host cell reactivation of damaged plasmid DNA. Biochemistry, 28. 3120-3124, 1989
32. Wei, Q., Matanoski, G. M., Farmer, E. R., Hedayati, M. A., and Grossman, L. DNA repair and aging in basal cell carcinoma: a molecular epidemiology study Proc. Natl Acad Sci. USA, 90: 1614-1618, 1993.
33. Smith, M. L., Chen, I-T., Zhan, Q., O'Connor, P. M., and Fornace, A. J., Jr. Involvement of the p53 tumor suppressor in repair of u v.-type DNA damage. Oncogene, 10: 1053-1059, 1995
34. Sancar, A. Mechanisms of DNA excision repair Science (Washington DC), 266: 1954-1956, 1994.
35. Haaawalt, P C Transcription-coupled repair and human disease. Science (Washington DC), 266: 1957-1958, 1994
36. Modrich, P. Mismatch repair, genetic stability, and cancer. Science (Washington DC), 266: 1959-1960, 1994.